Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus

Autoimmunity

Volumn 47, Issue 3, 2014, Pages 141-145

  Liang, Yan ^a   Xu, Wang Dong ^a   Yang, Xiao Ke ^a   Fang, Xin Yu ^a   Liu, Yan Yan ^a   Ni, Jing ^a   Qiu, Li Juan ^a   Hui, Peng ^a   Cen, Han ^a   Leng, Rui Xue ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphism; IFNs; Inflammation; SLE; STAT1

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FAS ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; STAT1 PROTEIN;

AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; MOUSE MODEL; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STAT1 GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION INITIATION; ANIMAL; CHEMISTRY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84904246061     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.873415     Document Type: Review

References (49)

1. Radic, M., M. Herrmann, J. van der Vlag, and O. P. Rekvig. 2011. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 44: 349-356.
2. Diaz, M. 2013. The role of activation-induced deaminase in lupus nephritis. Autoimmunity 46: 115-120.
3. Harada, T., V. Kyttaris, Y. Li, et al. 2007. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40: 1-8.
4. O'Shea, J. J., R. Lahesmaa, G. Vahedi, et al. 2011. Genomic views of STAT function in CD4 + T helper cell differentiation. Nat. Rev. Immunol. 11: 239-250.
5. Battle, T. E., and D. A. Frank. 2002. The role of STATs in apoptosis. Curr. Mol. Med. 2: 381-392.
6. Schindler, C., and C. Plumlee. 2008. Inteferons pen the JAK-STAT pathway. Semin. Cell Dev. Biol. 19: 311-318.
7. Hückel, M., U. Schurigt, A. H. Wagner, et al. 2006. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res. Ther. 8: R17.
8. Levy, D. E., and J. E. Darnell Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3: 651-662.
9. Kim, H. S., and M. S. Lee. 2007. STAT1 as a key modulator of cell death. Cell Signal 19: 454-465.
10. Boisson-Dupuis, S., X. F. Kong, S. Okada, et al. 2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24: 364-378.
11. Namjou, B., A. L. Sestak, D. L. Armstrong, et al. 2009. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60: 1085-1095.
12. Sandling, J. K., S. Garnier, S. Sigurdsson, et al. 2011. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur. J. Hum. Genet. 19: 479-484.
13. Abelson, A. K., A. M. Delgado-Vega, S. V. Kozyrev, et al. 2009. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68: 1746-1753.
14. Kanemitsu, S., K. Ihara, A. Saifddin, et al. 2002. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J. Rheumatol. 29: 1183-1188.
15. Yeh, H. M., C. Y. Yu, H. C. Yang, et al. 2013. Ubiquitin-specific protease 13 regulates IFN signaling by stabilizing STAT1. J. Immunol. 191: 3328-3336.
16. Coit, P., M. Jeffries, N. Altorok, et al. 2013. Genome-wide DNA methylation study suggests epigenetic accessibility and transcrip-tional poising of interferon-regulated genes in naïve CD4 + T cells from lupus patients. J. Autoimmun. 43: 78-84.
17. Panchanathan, R., H. Shen, X. Duan, et al. 2011. Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J. Immunol. 186: 6762-6770.
18. Panchanathan, R., X. Duan, H. Shen, et al. 2010. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J. Immunol. 185: 7385-7393.
19. Panchanathan, R., H. Liu, H. Liu, et al. 2012. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J. Immunol. 188: 270-278.
20. Hadj-Slimane, R., M. K. Chelbi-Alix, M. G. Tovey, and P. Bobé. 2004. An essential role for IFN-Alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. J. Interferon Cytokine Res. 24: 717-728.
21. Dong, J., Q. X. Wang, C. Y. Zhou, et al. 2007. Activation of the STAT1 signaling pathway in lupus nephritis in MRL/lpr mice. Lupus. 16: 101-109.
22. Sharabi, A., Z. M. Sthoeger, K. Mahlab, et al. 2009. A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-Affected (NZB x NZW) F1 mice. Clin. Immunol. 133: 61-68.
23. Klinman, D. M., D. Tross, S. Klaschik, et al. 2009. Therapeutic applications and mechanisms underlying the activity of immuno-suppressive oligonucleotides. Ann. N. Y. Acad. Sci. 1175: 80-88.
24. Fujimoto, M., H. Tsutsui, O. Xinshou, et al. 2004. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. 16: 303-314.
25. Scholz, J. L., M. A. Oropallo, V. Sindhava, et al. 2013. The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus. Lupus. 22: 350-360.
26. Karonitsch, T., E. Feierl, C. W. Steiner, et al. 2009. Activation of the interferon-gamma signaling pathway in systemic lupus erythe-matosus peripheral blood mononuclear cells. Arthritis Rheum. 60: 1463-1471.
27. Kuroiwa, T., R. Schlimgen, G. G. Illei, and D. T. Boumpas. 2003. Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis. Clin. Immunol. 106: 65-72.
28. Huang, X., Y. Guo, C. Bao, and N. Shen. 2011. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One 6: e21671.
29. Dai, R., Y. Zhang, D. Khan, et al. 2010. Identification of a common lupus disease-Associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302.
30. Lu, M. C., N. S. Lai, H. C. Chen, et al. 2013. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 171: 91-99.
31. Tang, Y., X. Luo, H. Cui, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075.
32. Martinez-Lostao, L., J. Ordi-Ros, F. Balada, et al. 2007. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus. 16: 483-488.
33. Gordon, R. A., G. Grigoriev, A. Lee, et al. 2012. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor a and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64: 3119-3128.
34. Karonitsch, T., K. von Dalwigk, C. W. Steiner, et al. 2012. Interferon signals and monocytic sensitization of the interferon-g signaling pathway in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum. 64: 400-408.
35. Nzeusseu Toukap, A., C. Galant, I. Theate, et al. 2007. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 56: 1579-1588.
36. Tsai, M. C., W. J. Chen, M. S. Tsai, et al. 2011. Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregula-tion of suppressor of cytokine signaling-3 in rats. J. Pineal Res. 51: 233-245.
37. Hadj-Slimane, R., M. K. Chelbi-Alix, M. G. Tovey, and P. Bobé. 2004. An essential role for IFN-Alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. J. Interferon Cytokine Res. 24: 717-728.
38. Hofer, M. J., W. Li, P. Manders, et al. 2012. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+T-cell-mediated disease following infection with lymphocytic choriome-ningitis virus. J. Virol. 86: 6932-6946.
39. Pulit-Penaloza, J. A., S. V. Scherbik, and M. A. Brinton. 2012. Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation. Virology. 425: 71-81.
40. Lu, Y., L. Li, H. Yan, et al. 2013. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. Int. J. Cardiol. 168: 5396-5404.
41. Miyake, K., M. Akahoshi, and H. Nakashima. 2011. Th subset balance in lupus nephritis. J. Biomed. Biotechnol. 2011: 980286.
42. Santini, S. M., C. Lapenta, L. Santodonato, et al. 2009. IFN-Alpha in the generation of dendritic cells for cancer immunotherapy. Handb. Exp. Pharmacol. 188: 295-317.
43. McCoy, L., I. Tsunoda, and R. S. Fujinami. 2006. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39: 9-19.
44. Hale, M. B., P. O. Krutzik, S. S. Samra, et al. 2009. Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One. 4: e6756.
45. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226: 41-56.
46. Ivashkiv, L. B. 2003. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity 36: 473-479.
47. Georg, P., and I. Bekeredjian-Ding. 2012. Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity 45: 579-583.
48. Parcina, M., M. Schiller, A. Gierschke, et al. 2009. PDC expressing CD36, CD61 and IL-10 may contribute to propagation of immune tolerance. Autoimmunity 42: 353-355.
49. Funae, O., A. Shimada, M. Tokui, et al. 2001. Balance of GAD65-specific IL-10 production and polyclonal Th1-type response in type 1 diabetes. Autoimmunity 34: 45-52.